News Quantified

TNDM – tandem diabetes care, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Tandem Diabetes Care (TNDM) had its "buy" rating reaffirmed by TD Cowen.

Tandem Diabetes Care (TNDM) had its price target lowered by The Goldman Sachs Group, Inc. from $28.00 to $25.00. They now have a "neutral" rating on the stock.

Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Weakness [Yahoo! Finance]

Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026

Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm

32.7%

BEAT

22.0%

IN-LINE

-19.9%

MISS

18.6%

MISS

Form 4 TANDEM DIABETES CARE For: Apr 15 Filed by: Kyrillos Jean-Claude

Form ARS TANDEM DIABETES CARE For: Dec 31

Form DEF 14A TANDEM DIABETES CARE For: Dec 31

Form DEFA14A TANDEM DIABETES CARE

Form PRE 14A TANDEM DIABETES CARE For: Dec 31

Top News Gainers

3/27 Tandem Diabetes Care Inc (NASDAQ: TNDM) had its price target lowered by analysts at Citigroup Inc from $89.00 to $74.00. They now have a "neutral" rating on the stock. 10.3%

10/14 Tandem Diabetes Care to Announce Third Quarter 2019 Financial Results on November 4, 2019 9.5%

11/4 Form 10-Q TANDEM DIABETES CARE For: Sep 30 7.6%

4/1 Keller Grover LLP Investigating Tandem Diabetes Care 7.0%

8/1 Q2/2019 6/30/2019 EPS -0.030 ZacksConsensus -0.230 ActVsEst 0.200 - Beat 7.0%

5/13 Tandem Diabetes Care Announces Upcoming Conference Presentations 6.8%

2/10 Form SC 13G/A TANDEM DIABETES CARE Filed by: WELLINGTON MANAGEMENT GROUP LLP 6.8%

4/29 Tandem Diabetes Care Q1 2020 Earnings Preview [Seeking Alpha] 5.8%

11/18 Form 4 TANDEM DIABETES CARE For: Nov 18 Filed by: Vosseller Leigh 5.8%

3/2 Tandem Diabetes Care Announces FDA Designation of Basal-IQ Technology as an Interoperable Automated Glycemic Controller 5.7%

Top News Decliners

3/14 Tandem Diabetes Care Inc (NASDAQ: TNDM) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -15.8%

2/24 Q4/2019 12/31/2019 EPS 0.040 ZacksConsensus -0.080 ActVsEst 0.120 - Beat -11.9%

11/4 Q3/2019 9/30/2019 EPS -0.090 ZacksConsensus -0.200 ActVsEst 0.110 - Beat -7.6%

6/7 Tandem Diabetes Care Announces Conference Call Following Data Presentations at the ADA Scientific Sessions -6.4%

8/14 Form 4 TANDEM DIABETES CARE For: Aug 13 Filed by: CAHILL EDWARD L -6.1%

10/1 2 Growth Stocks for In-the-Know Investors [The Motley Fool] -5.9%

8/13 Form 4 TANDEM DIABETES CARE For: Aug 12 Filed by: HANSEN BRIAN B -5.4%

8/6 Form 4 TANDEM DIABETES CARE For: Aug 02 Filed by: ROEDER DOUGLAS A -4.7%

8/30 Form 4 TANDEM DIABETES CARE For: Aug 28 Filed by: BLICKENSTAFF KIM D -4.6%

1/30 Tandem Diabetes Care Inc (NASDAQ: TNDM) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day